MERTK mutation update in inherited retinal diseases

Isabelle Audo,Saddek Mohand‐Said,Elise Boulanger‐Scemama,Xavier Zanlonghi,Christel Condroyer,Vanessa Démontant,Fiona Boyard,Aline Antonio,Cécile Méjécase,Said El Shamieh,José‐Alain Sahel,Christina Zeitz,Saddek Mohand-Said,Elise Boulanger-Scemama,José-Alain Sahel

DOI: https://doi.org/10.1002/humu.23431

2018-05-23

Human Mutation

Abstract:MER tyrosine kinase (MERTK) encodes a surface receptor localized at the apical membrane of the retinal pigment epithelium. It plays a critical role in photoreceptor outer segment internalization prior to phagocytosis. Mutations in MERTK have been associated with severe autosomal recessive retinal dystrophies in the RCS rat and in humans. We present here a comprehensive review of all reported MERTK disease causing variants with the associated phenotype. In addition, we provide further data and insights of a large cohort of 1,195 inherited retinal dystrophies (IRD) index cases applying state-of-the-art genotyping techniques and summarize current knowledge. A total of 79 variants have now been identified underlying rod-cone dystrophy and cone-rod dystrophy including 11 novel variants reported here. The mutation spectrum in MERTK includes 33 missense, 12 nonsense, 12 splice defects, 12 small deletions, two small insertion-deletions, three small duplications, and two exonic and three gross deletions. Altogether, mutations in MERTK account for ∼2% of IRD cases with a severe retinal phenotype. These data are important for current and future therapeutic trials including gene replacement therapy or cell-based therapy.

genetics & heredity